Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

7.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations.

Expert review of clinical pharmacology·2021
Same author

Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention.

International journal of cardiology·2021
Same author

Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.

JAMA cardiology·2021
Same author

Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials.

Current opinion in cardiology·2021
Same author

Tackling the gap in platelet inhibition with oral antiplatelet agents in high-risk patients undergoing percutaneous coronary intervention.

Expert review of cardiovascular therapy·2021
Same author

Systematic Assessment of Online Health Information for Coronary Revascularization.

JAMA internal medicine·2021

Related Experiment Video

Updated: May 2, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K

Platelet function testing in contemporary clinical and interventional practice.

Francesco Franchi1, Fabiana Rollini, Jung Rae Cho

  • 1University of Florida College of Medicine-Jacksonville, 655 West 8th Street, Jacksonville, FL, 32209, USA, francesco.franchi@jax.ufl.edu.

Current Treatment Options in Cardiovascular Medicine
|March 22, 2014
PubMed
Summary
This summary is machine-generated.

Platelet function testing assesses antiplatelet therapy effectiveness, but clinical trials haven't proven personalized treatment improves outcomes. Further research is needed to optimize its use in acute coronary syndrome and percutaneous coronary intervention patients.

More Related Videos

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

924
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

16.3K

Related Experiment Videos

Last Updated: May 2, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

924
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

16.3K

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Dual antiplatelet therapy (aspirin and P2Y12 inhibitor) is standard for acute coronary syndrome and percutaneous coronary intervention.
  • Individual response variability to antiplatelet drugs, especially clopidogrel, can lead to ischemic events like stent thrombosis.
  • Platelet function testing measures drug efficacy and has prognostic implications for thrombotic and bleeding risks.

Purpose of the Study:

  • To provide an overview of platelet function testing in current clinical and interventional practice.
  • To discuss the role of platelet function testing in optimizing antiplatelet therapy.
  • To examine the correlation between platelet reactivity and clinical outcomes.

Main Methods:

  • Review of existing literature on platelet function testing and antiplatelet therapy.
  • Analysis of studies investigating optimal platelet reactivity ranges.
  • Evaluation of clinical trials on personalized antiplatelet therapy strategies.

Main Results:

  • Platelet function testing is valuable for assessing antiplatelet drug efficacy.
  • High and low platelet reactivity are associated with increased thrombotic and bleeding risks, respectively.
  • Major clinical trials have not demonstrated a benefit of personalized antiplatelet therapy in improving clinical outcomes.

Conclusions:

  • Despite its value in assessing drug efficacy, personalized antiplatelet therapy guided by platelet function testing has not yet shown clinical benefit.
  • Limitations in current clinical trials may explain the lack of demonstrated benefit.
  • Further investigation is needed to refine the role and application of platelet function testing in patient care.